PremiumThe FlyEvolent Health reports Q1 adjusted EPS 6c, consensus 10c Evolent Health sees Q2 revenue $440M-$470M, consensus $503.67M Evolent Health sees 2025 revenue $2.06B-$2.11B, consensus $2.07B PremiumThe FlyEvolent Health price target lowered to $14 from $15 at Truist Evolent Health price target lowered to $12 from $13 at JPMorgan Evolent Health price target raised to $13 from $12 at Citizens JMP PremiumCompany AnnouncementsEvolent Health Reports Growth and Strategic Gains Evolent Health Positioned for Growth Amidst Contractual Strength and Strategic Investments Evolent Health sees FY25 revenue $2.06B-$2.11B, consensus $2.42B 
